FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W4309472912> ?p ?o ?g. }

• W4309472912 endingPage "239" @default.
• W4309472912 startingPage "233" @default.
• W4309472912 abstract "There have been a growing number of treatment options available for men with metastatic castration-sensitive prostate cancer. Not only have newer agents entered the clinical landscape, there is a trend toward treatment intensification by combining multiple agents simultaneously. We aim to assess the best contemporary treatment option for men with mCSPC.We perform an updated systematic review and network meta-analysis of randomized control trials that evaluated systemic therapies in men with castration-sensitive prostate cancer. We searched multiple databases up to April 2022. We included all randomized trials assessing the effect of systemic agents. We performed subgroup analyses based on disease volume and timing of presentation. Statistical analysis was performed with Bayesian methods.We found 10 eligible trials with 10,065 patients who were included in this analysis. Triplet therapy with darolutamide or abiraterone with docetaxel and ADT improved overall survival. In the sensitivity analysis, the respective hazard ratios for triplet therapy was HR 0.70 (95%CI 0.61-0.80) compared to docetaxel+ADT and 0.77 (95%CI 0.65-0.91) compared to androgen receptor pathway inhibitors+ADT combinations. It was estimated that there was 96% chance that one of the triplet therapy combinations were the best treatment option from an OS perspective. Triplet therapy also improved progression-free survival. These benefits were pronounced in men with high-volume disease burden and those with de novo metastatic disease.The finding suggest that triplet therapy is likely the most efficacious available option in men with metastatic, castration-sensitive prostate cancer, especially in those with high-volume disease burden." @default.
• W4309472912 created "2022-11-28" @default.
• W4309472912 creator A5007821932 @default.
• W4309472912 creator A5021906019 @default.
• W4309472912 creator A5033260494 @default.
• W4309472912 creator A5040246688 @default.
• W4309472912 creator A5044519122 @default.
• W4309472912 creator A5075093609 @default.
• W4309472912 creator A5081221251 @default.
• W4309472912 creator A5083886265 @default.
• W4309472912 date "2023-05-01" @default.
• W4309472912 modified "2023-10-03" @default.
• W4309472912 title "Emergence of triplet therapy for metastatic castration-sensitive prostate cancer: An updated systematic review and network meta-analysis" @default.
• W4309472912 cites W2178183066 @default.
• W4309472912 cites W2214621962 @default.
• W4309472912 cites W2620746860 @default.
• W4309472912 cites W2620798309 @default.
• W4309472912 cites W2754672431 @default.
• W4309472912 cites W2777183039 @default.
• W4309472912 cites W2783782279 @default.
• W4309472912 cites W2787804990 @default.
• W4309472912 cites W2788160989 @default.
• W4309472912 cites W2788841415 @default.
• W4309472912 cites W2802053856 @default.
• W4309472912 cites W2912565296 @default.
• W4309472912 cites W2913023403 @default.
• W4309472912 cites W2938589827 @default.
• W4309472912 cites W2947014957 @default.
• W4309472912 cites W2947893479 @default.
• W4309472912 cites W2963794755 @default.
• W4309472912 cites W2969575782 @default.
• W4309472912 cites W2975006240 @default.
• W4309472912 cites W2975895768 @default.
• W4309472912 cites W2983492159 @default.
• W4309472912 cites W2989651221 @default.
• W4309472912 cites W2995928704 @default.
• W4309472912 cites W3019962442 @default.
• W4309472912 cites W3049620688 @default.
• W4309472912 cites W3106631792 @default.
• W4309472912 cites W3115922869 @default.
• W4309472912 cites W3157858132 @default.
• W4309472912 cites W3158318954 @default.
• W4309472912 cites W3161737617 @default.
• W4309472912 cites W3164510972 @default.
• W4309472912 cites W3165100722 @default.
• W4309472912 cites W3170331504 @default.
• W4309472912 cites W3194237726 @default.
• W4309472912 cites W4200095907 @default.
• W4309472912 cites W4200390731 @default.
• W4309472912 cites W4205387542 @default.
• W4309472912 cites W4212967167 @default.
• W4309472912 cites W4213196409 @default.
• W4309472912 cites W4220959221 @default.
• W4309472912 cites W4221060446 @default.
• W4309472912 cites W4221135453 @default.
• W4309472912 cites W4223437636 @default.
• W4309472912 cites W4223443163 @default.
• W4309472912 cites W4224078346 @default.
• W4309472912 cites W4225259757 @default.
• W4309472912 cites W4232188906 @default.
• W4309472912 cites W4280599443 @default.
• W4309472912 doi "https://doi.org/10.1016/j.urolonc.2022.10.016" @default.
• W4309472912 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/36411180" @default.
• W4309472912 hasPublicationYear "2023" @default.
• W4309472912 type Work @default.
• W4309472912 citedByCount "3" @default.
• W4309472912 countsByYear W43094729122023 @default.
• W4309472912 crossrefType "journal-article" @default.
• W4309472912 hasAuthorship W4309472912A5007821932 @default.
• W4309472912 hasAuthorship W4309472912A5021906019 @default.
• W4309472912 hasAuthorship W4309472912A5033260494 @default.
• W4309472912 hasAuthorship W4309472912A5040246688 @default.
• W4309472912 hasAuthorship W4309472912A5044519122 @default.
• W4309472912 hasAuthorship W4309472912A5075093609 @default.
• W4309472912 hasAuthorship W4309472912A5081221251 @default.
• W4309472912 hasAuthorship W4309472912A5083886265 @default.
• W4309472912 hasConcept C121608353 @default.
• W4309472912 hasConcept C126322002 @default.
• W4309472912 hasConcept C143998085 @default.
• W4309472912 hasConcept C168563851 @default.
• W4309472912 hasConcept C187960798 @default.
• W4309472912 hasConcept C207103383 @default.
• W4309472912 hasConcept C2775832370 @default.
• W4309472912 hasConcept C2776551883 @default.
• W4309472912 hasConcept C2777899217 @default.
• W4309472912 hasConcept C2778971682 @default.
• W4309472912 hasConcept C2780192828 @default.
• W4309472912 hasConcept C2781190966 @default.
• W4309472912 hasConcept C44249647 @default.
• W4309472912 hasConcept C509974204 @default.
• W4309472912 hasConcept C535046627 @default.
• W4309472912 hasConcept C61367390 @default.
• W4309472912 hasConcept C71924100 @default.
• W4309472912 hasConcept C95190672 @default.
• W4309472912 hasConceptScore W4309472912C121608353 @default.
• W4309472912 hasConceptScore W4309472912C126322002 @default.
• W4309472912 hasConceptScore W4309472912C143998085 @default.
• W4309472912 hasConceptScore W4309472912C168563851 @default.

• next